Mastoid cavity obliteration leads to a clinically significant improvement in health-related quality of life
| Autor: | Robert Mlynski, David Bächinger, Jannik Botzen, Nora M Weiss, Wilma Großmann |
|---|---|
| Přispěvatelé: | University of Zurich, Weiss, Nora M |
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Chronic middle ear disease Mastoidectomy medicine.medical_treatment Otology 610 Medicine & health 10045 Clinic for Otorhinolaryngology Mastoid Tympanoplasty Bone conduction Quality of life medicine Humans Prospective Studies Chronic otitis media Cholesteatoma Obliteration Mastoid cavity Retrospective Studies ZCMEI-21 Cholesteatoma Middle Ear business.industry General Medicine Middle Aged medicine.disease Surgery Treatment Outcome 2733 Otorhinolaryngology medicine.anatomical_structure Otorhinolaryngology Quality of Life Middle ear Female Neurosurgery business |
| Zdroj: | European Archives of Oto-Rhino-Laryngology |
| ISSN: | 1434-4726 0937-4477 |
| DOI: | 10.1007/s00405-020-05881-4 |
| Popis: | Objective To assess the change in health-related quality of life (HRQoL) in patients undergoing mastoid cavity obliteration. Methods Patients who had undergone canal wall-down mastoidectomy for chronic otitis media with creation of a persistent mastoid cavity and underwent revision tympanomastoid surgery including mastoid cavity obliteration using autologous material were included. Audiological measurements including air conduction (AC) and bone conduction (BC) pure-tone averages (PTA) and the air–bone gap (ABG) were assessed. Health-related Quality of Life (HRQoL) was assessed by the Zurich Chronic Middle Ear Inventory (ZCMEI-21) pre- and postoperatively. Results A total of 25 patients (16 females and 9 males; mean age 51.6 years, 14 right and 11 left ears) were included. Patients were reexamined after a mean follow-up period of 9.2 months (SD = 6.5) after obliteration of the mastoid cavity. Compared to the preoperative visit, patients showed a significantly reduced AC PTA at the postoperative visit (mean difference: − 4.1; SD = 10.4, p = 0.045). The mean ZCMEI-21 score changed from 31.7 (SD = 14.5) preoperatively to 17.4 (SD = 15.1) postoperatively (mean difference: − 14.3; SD = 19.1; p = 0.0002). The mean ZCMEI-21 score changes were neither correlated to the AC PTA shift (p = 0.60) nor to the ABG shift (p = 0.66). Conclusions This is the first study reporting a highly significant and clinically important improvement in HRQoL after mastoid cavity obliteration in a prospective setting. The improvement in HRQoL was not correlated to the hearing improvement. As a clinical implication, we provide evidence for a substantial subjective benefit of the surgical obliteration of a symptomatic mastoid cavity and, therefore, encourage this surgical procedure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink